Le Lézard
Classified in: Health
Subject: EGV

The European Society of Endocrinology Meets With European Parliament Members to Discuss Limiting the Socioeconomic Impact of Osteoporosis in Europe


MILAN, October 18, 2018 /PRNewswire/ --

In Brussels, the European Society of Endocrinology has met 10 European Parliament members and proposed a shared agenda to limit the socioeconomic impact of Osteoporosis in Europe.

Tackling hypovitaminosis D, early diagnosis of vertebral fractures, access and adherence to therapies are the key points to work on.

     (Logo: https://mma.prnewswire.com/media/770911/The_European_Society_of_Endocrinology_Logo.jpg )

Affecting more than half of population aged over 80, osteoporosis represents an emergency in terms of social relevance and economic - healthcare costs.  The European Society of Endocrinology seizes the opportunity of the World Osteoporosis Day to meet European Authorities and set forth a proposal of shared healthcare policies that may produce large-scale benefits and improve people's health and State budgets.

 

"Fragility fractures have an important economic impact.  The direct costs (hospitalizations) only in Italy account for around 9 billion euros. 1 more billion of indirect costs, such as rehabilitation costs and losses due to absence from work, has to be added. We find the same situation in the rest of EU States as well - says Prof. Andrea Giustina, Professor of Endocrinology at San Raffaele Hospital in Milan and President-Elect of the European Society of Endocrinology - The three-point document we will set forth to the EP members proposes some cost-effective measures of clinical practice aimed at limiting costs and drastically reducing the incidence of this disease."

The document prepared by the ESE is set out in 3 points:


"European endocrinologists wish that this agenda of intervention might gain the widest consent among Institutions and are ready to help in order to find in practice the most effective instruments to implement intervention on the mentioned criticalities. They also commit themselves to verify the execution and effectiveness of said instruments 12 months hence," concludes Giustina.


These press releases may also interest you

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...



News published on and distributed by: